AFS and Trading Securities - Unrealized Loss Position (<12 Months) Fair Value

Gilead Sciences AFS and Trading Securities - Unrealized Loss Position (<12 Months) Fair Value decreased by 7.6% to $669.00M in Q1 2026 compared to the prior quarter. Over 2 years (FY 2022 to FY 2025), AFS and Trading Securities - Unrealized Loss Position (<12 Months) Fair Value shows a downward trend with a -22.5% CAGR. This is a positive signal — lower values indicate better performance for this metric.

Analysis

StatementBalance Sheet Statement

SectionCurrent Assets

CategoryRisk

SignalLower is better

VolatilityModerate

First reportedQ4 2017

Last reportedQ1 2026May 7, 2026

How to read this metric

A high value may indicate short-term market volatility affecting the portfolio, while a low value suggests portfolio stability.

Detailed definition

The fair value of debt securities classified as available-for-sale or trading that are currently in an unrealized loss p...

Peer comparison

Commonly used in financial services to assess the duration and severity of investment portfolio impairments.

Metric ID: afs_debt_securities_unrealized_loss_less_12m_fv

Historical Data

8 periods

	Q4 '22	Q1 '23	Q2 '23	Q3 '23	Q4 '23	Q2 '25	Q4 '25	Q1 '26
Value	$1.20B	$862.00M	$1.25B	$1.24B	$727.00M	$519.00M	$724.00M	$669.00M
QoQ Change	—	-28.4%	+44.5%	-0.6%	-41.3%	-28.6%	+39.5%	-7.6%
YoY Change	—	—	—	—	-39.6%	—	—	—

Range$519.00M – $1.25B

CAGR-28.5%

Avg YoY Growth-39.6%

Median YoY Growth-39.6%

AFS and Trading Securities - Unrealized Loss Position (<12 Months) Fair Value at Other Companies

KKR & Co.KKR View metric

M&T BankMTB View metric

The Travelers CompaniesTRV View metric

Bank of AmericaBAC View metric

KKR & Co.KKR View metric

Frequently Asked Questions

What is Gilead Sciences's afs and trading securities - unrealized loss position (<12 months) fair value?: Gilead Sciences (GILD) reported afs and trading securities - unrealized loss position (<12 months) fair value of $669.00M in Q1 2026.
What is the long-term trend for Gilead Sciences's afs and trading securities - unrealized loss position (<12 months) fair value?: Over 2 years (2022 to 2025), Gilead Sciences's afs and trading securities - unrealized loss position (<12 months) fair value has grown at a -22.5% compound annual growth rate (CAGR), from $1.20B to $724.00M.
What does afs and trading securities - unrealized loss position (<12 months) fair value mean?: The current market value of debt investments that have been worth less than their cost for less than a year.